Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biomark Diagnostics Inc (BUX.CN)

Biomark Diagnostics Inc (BUX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomark Diagnostics Inc 130 - 3851 Shell Road Richmond BC V6X 2W2 CAN

https://www.biomarkdiagnostics.com P: 604-836-6950

Description:

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Key Statistics

Overview:

Market Capitalization, $K 25,448
Shares Outstanding, K 90,886
Annual Sales, $ 153 K
Annual Net Income, $ -1,842 K
Last Quarter Sales, $ 42 K
Last Quarter Net Income, $ -407 K
60-Month Beta -1.39
% of Institutional Shareholders 63.07%

Growth:

1-Year Return 12.00%
3-Year Return -42.86%
5-Year Return 250.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.02
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 101.50%
Dividend Payout Ratio 0.00%

BUX.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % -137.66%
Profit Margin % -1,200.21%
Debt/Equity N/A
Price/Sales 145.22
Price/Book N/A
Book Value/Share -0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar